Electro Optic Systems: Real Counter-Drone Growth, But The Price Got There First

Electro Optic Systems, a 40-year-old Australian maker of defense and space technology, has become one of the purest public plays on the counter-drone boom — the scramble by governments to shoot down the small drones that now dominate modern battlefields. Over the past year the shares have more than doubled, to roughly A$9, lifting the company's market value toward A$2.1 billion. And the business is delivering exactly the growth the market is celebrating, with record revenue and its first real profit at the operating level. That is the part investors have right. The harder question — the one worth slowing down for — is whether the price already did its slapping for the good news, leaving little room for anything to go wrong. All figures are in Australian dollars.

The record half is real demand, not a pitch

The most recent half-year, the six months to June 30, produced the numbers that justify the enthusiasm. Revenue came in at A$168.8 million, roughly triple the prior-year period, driven by the Defence Systems business and the acquisition of MARSS, a maker of counter-drone command-and-control systems. Underlying EBITDA swung to a positive A$21 million from a loss of A$14.9 million a year earlier — the first time the company has posted a profit of that scale. The order book, the truest measure of whether future revenue is actually locked in rather than hoped for, stood at more than A$846 million after A$303 million of new contracts landed during the half. The balance sheet is in good shape, with A$256 million in cash at June 30.

None of this is a narrative without evidence. Middle East customers have ordered its Slinger counter-drone weapon; it won an order from L3Harris in the United States. This is demand converting into purchase orders, which is precisely the proof the story needs. Whatever complaint an investor might raise about Electro Optic Systems, "no one is buying their products" is not it.

What the price is actually paying for

But a good company and a good stock are different things, and the gap between them is the whole debate here. The market cap of roughly A$2.1 billion is not small relative to what the company currently earns. Electro Optic Systems still reports a statutory net loss — about A$33 million for the half, a figure inflated by a non-cash A$34 million fair-value charge tied to the MARSS deal — so there is no earnings multiple to anchor on. Its gross margin slipped from 76% to 58%, in part because the prior-year period carried one-off contract income.

Put revenue next to the price and the gap appears quickly. The company's full-year guidance is A$360 million to A$400 million including MARSS. Against that, a A$2.1 billion market cap is roughly five times forecast revenue — with the profit engine still essentially unproven. That multiple is not a statement that revenue will keep growing; it is a bet that the profit follows the revenue. The margin decline shows the road there is not automatic.

The next two quarters decide whether the bridge closes

Management has raised the full-year revenue target to A$360 million to A$400 million after bringing MARSS into the fold. The June order book of A$726 million was expected to convert 60% to 80% into revenue across fiscal 2026 and 2027, and MARSS alone carries a pipeline it thinks could reach EUR1 billion within twelve months. Those are the numbers that would let the company grow into its valuation.

They are also the numbers that could cut the other way. Contracts of this type are lumpy and delivery-dependent; revenue recognition for the newly acquired MARSS business was still under assessment at reporting time, and the timing of equipment deliveries is hostage to global supply chains. The point is not that any of these is failing. It is that the stock's premium now depends on everything converting on schedule, in an integration the company has only just begun, with a margin that already ticked down. When the good news is fully documented and the profit still has to be delivered, execution slip is what the multiple is exposed to.

The honest read here separates the business from the price. The business has earned its reputation, and the demand behind it is real. But the share price has already done much of the work — it ran up roughly half again in the month before the results and trades at a premium that assumes the profit engine starts working in the next two or three quarters. For an investor who missed the run, paying up here means funding MARSS integration and backlog conversion before the evidence confirms they will pay off. That is a reason to like the company and hold off on the stock until the next half-year proves the bridge actually closes.